A Phase III study of subcutaneous doses of glepaglutide for short bowel syndrome (SBS).
Phase of Trial: Phase III
Latest Information Update: 24 Jan 2018
At a glance
- Drugs Glepaglutide (Primary)
- Indications Short bowel syndrome
- Focus Therapeutic Use
- 24 Jan 2018 New trial record
- 23 Jan 2018 According to a Zealand Pharma media release, this trial is expected to initiate in late 2018.
- 23 Jan 2018 According to a Zealand Pharma media release, the company is planning to initiate this trial in 2018.